Novartis in the lead to acquire cancer drug developer MorphoSys-sources

cafead

Administrator
Staff member
  • cafead   Feb 05, 2024 at 11:42: AM
via Drug maker Novartis AG NOVN.S is in advanced talks to acquire MorphoSys AG MORG.DE, a developer of cancer treatments that has a market value of 1.6 billion euros ($1.7 billion), two people familiar with the matter said on Monday.

article source